December 15, 2025: Wegovy May Interfere with Imaging Studies, New Research Reveals Thousands of people in the United States use Wegovy to manage their weight
Indications: type II diabetes mellitus a supplement to sulfonylurea or insulin therapy Contraindications: type 1 diabetes or for the treatment of diabetic ketoacidosis patients with a history of heart failure active liver disease (or elevated transaminase levels) - due to increased risk of hepatic injury Pharmacokinetics: metabolized through the hepatic cytochrome P450 system FDA Warnings / Safety Concerns & Availability Issues: Several previous clinical trials suggested that rosiglitazone (but not pioglitazone) may increase the risk of myocardial infarction
Integrating the clinical context with the results of total B12, and where indicated, considering second-line tests such as HCY and potentially MMA, will be crucial in navigating the updated Medicare landscape while ensuring optimal patient care
20 This observation emphasizes their potential to promote systemic metabolic health beyond glucose homeostasis and makes GLP-1RAs a more suitable treatment option for T2D patients with a higher risk of cardiovascular disease compared to metformin
A milestone discovery was made regarding the mutated gene leptin found in ob/ob mice, which exhibit hyperlipidemia and IR
How does PlexusDx support the decision between these options